Cite
HARVARD Citation
Malagola, M. et al. (n.d.). Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era. American journal of hematology. 89 (2), pp. 119-124. [Online].